PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

114 hedge funds and large institutions have $588M invested in Phathom Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
1.65%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.13%
New
13
Increased
40
Reduced
35
Closed
16
Calls
$811K
Puts
$991K
Net Calls
-$180K
Net Calls Change
-$518K

Top Buyers

1
MVM
1
Medicxi Ventures Management
Jersey
$79.3M
2
Jennison Associates
2
Jennison Associates
New York
$17.5M
3
PBM
3
Propel Bio Management
California
$9.24M
4
OCA
4
Octagon Capital Advisors
New York
$4.83M
5
6CM
5
683 Capital Management
New York
$17.5M

Top Sellers

1
TPC
1
Takeda Pharmaceutical Company
Japan
$33.5M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$223K
3
WP
3
Woodline Partners
California
$6.02M
4
NM
4
Newtyn Management
New York
$1.75M
5
GGHC
5
Gilder Gagnon Howe & Co
New York
$10.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
OCA
26
Octagon Capital Advisors
New York
$4.83M +$4.3M +405,000 +810%
CC
27
Checkpoint Capital
California
$4.73M +$910K +85,715 +24%
SG
28
StepStone Group
California
$4.48M – – –
EAM
29
Eagle Asset Management
Florida
$3.23M +$3.23M +304,839 New
Northern Trust
30
Northern Trust
Illinois
$3.01M -$70.3K -6,619 -2%
Charles Schwab
31
Charles Schwab
California
$2.81M +$20.9K +1,970 +0.8%
Nuveen Asset Management
32
Nuveen Asset Management
Illinois
$2.78M -$452K -42,561 -14%
Morgan Stanley
33
Morgan Stanley
New York
$2.52M -$127K -11,942 -5%
Millennium Management
34
Millennium Management
New York
$2.39M +$584K +54,980 +32%
Wellington Management Group
35
Wellington Management Group
Massachusetts
$2.37M +$733K +68,999 +45%
Goldman Sachs
36
Goldman Sachs
New York
$2.2M -$30.2K -2,839 -1%
NM
37
Newtyn Management
New York
$1.75M -$5.12M -481,760 -74%
SSA
38
Schonfeld Strategic Advisors
New York
$1.54M +$889K +83,700 +137%
JPMorgan Chase & Co
39
JPMorgan Chase & Co
New York
$1.47M -$80.6K -7,585 -5%
Citadel Advisors
40
Citadel Advisors
Florida
$1.33M +$1.21M +114,112 +989%
MCM
41
Moore Capital Management
New York
$1.27M +$212K +20,000 +20%
Bank of America
42
Bank of America
North Carolina
$1.12M +$256K +24,062 +29%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.01M -$118K -11,098 -10%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$681K -$693K -65,251 -50%
PMAM
45
Penn Mutual Asset Management
Pennsylvania
$667K – – –
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$631K +$75.7K +7,124 +14%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$629K +$126K +11,872 +25%
Swiss National Bank
48
Swiss National Bank
Switzerland
$595K – – –
Two Sigma Advisers
49
Two Sigma Advisers
New York
$548K +$307K +28,900 +127%
UBS Group
50
UBS Group
Switzerland
$530K +$111K +10,491 +27%
1
2
3 4 5